EUVIMEDEUVIMED entdecken
Crossref

Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability

André Campaniço iD, Shrika G Harjivan iD, Elisabete Freitas, Marco Serafini iD, M Manuela Gaspar iD, Rita Capela iD, Pedro Gomes, Audrey Jordaan, Ana M Madureira iD, Vânia André iD, Andreia B Silva iD, M Teresa Duarte iD und 5 weitere

ChemMedChem · 2023

DOI: 10.1002/cmdc.202300410 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von André Campaniço und 16 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portu…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Fundação para a Ciência e Tecnologia, FCT and FEDER, FCT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While N ‐acetyl azaaurones have already been disclosed for their potential against tuberculosis (TB), their low metabolic stability remains an unaddressed liability. We now report a study designed to improve the metabolic stability and solubility of the azaaurone scaffold and to identify the structural requirements for antimycobacterial activity. Replacing the N ‐acetyl moiety for a N ‐carbamoyl group led to analogues with sub‐ and nanomolar potencies against M. tuberculosis H37Rv, as well as equipotent against drug‐susceptible and drug‐resistant M. tuberculosis isolates. The new N ‐carbamoyl azaaurones exhibited improved microsomal stability, compared to their N ‐acetylated counterparts, with several compounds displaying moderate to high kinetic solubility. The frequency of spontaneous resistance to azaaurones was observed to be in the range of 10 −8 , a value that is comparable to current TB drugs in the market. Overall, these results reveal that azaaurones are amenable to structural modifications to improve metabolic and solubility liabilities, and highlight their potential as antimycobacterial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisHumansAntitubercular AgentsSolubilityMicrobial Sensitivity TestsBenzofurans

Stichwörter der Autor:innen

M. tuberculosisazaauronesdrug discoverydrug-resistant tuberculosisstructure-activity relationships

Substanzen

Antitubercular AgentsazaauroneBenzofurans

Autor:innen und Institutionen

  • Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Molecular Mycobacteriology Research Unit, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, Rondebosch, 7701, South Afric…
  • Centro de Química Estrutural, Institute of Molecular Sciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001, Lisboa, Portugal.
  • Associação do Instituto Superior Técnico para a Investigação e Desenvolvimento (IST-ID), Avenida António José de Almeida, n.° 12, 1000-043, Lisboa, Portugal.
  • Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003, Lisboa, Portugal.
  • Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, Rondebosch, 7701, South Africa.

ORCID-Profile: André Campaniço, Shrika G Harjivan, Marco Serafini, M Manuela Gaspar, Rita Capela, Ana M Madureira, Vânia André, Andreia B Silva, M Teresa Duarte, Isabel Portugal, João Perdigão, Rui Moreira, Digby F Warner, Francisca Lopes

Förderung

  • Fundação para a Ciência e Tecnologia
  • FCT and FEDER
  • FCT
  • Strategic Health Innovation 532 Partnerships
  • South African Medical Research Council
  • National 533 Treasury under its Economic Competitiveness and Support Package
  • FEDER

Zitieren

APA

Campaniço, A., Harjivan, S. G., Freitas, E., Serafini, M., Gaspar, M. M., Capela, R., Gomes, P., Jordaan, A., Madureira, A. M., André, V., Silva, A. B., Duarte, M. T., Portugal, I., Perdigão, J., Moreira, R., Warner, D. F., & Lopes, F. (2023). Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability. ChemMedChem. https://doi.org/10.1002/cmdc.202300410

Vancouver

Campaniço A, Harjivan SG, Freitas E, Serafini M, Gaspar MM, Capela R, et al. Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability. ChemMedChem. 2023. doi:10.1002/cmdc.202300410

BibTeX
@article{Campanio2023,
  author = {Campaniço, André and Harjivan, Shrika G and Freitas, Elisabete and Serafini, Marco and Gaspar, M Manuela and Capela, Rita and Gomes, Pedro and Jordaan, Audrey and Madureira, Ana M and André, Vânia and Silva, Andreia B and Duarte, M Teresa and Portugal, Isabel and Perdigão, João and Moreira, Rui and Warner, Digby F and Lopes, Francisca},
  title = {Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability},
  journal = {ChemMedChem},
  year = {2023},
  doi = {10.1002/cmdc.202300410}
}
Kostenlos starten →